Smithfield Trust’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
MMEA
Smithfield Trust's ARKG Position: Q3 2024 in Review
Smithfield Trust sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2024, closing a stake of 71 shares — an estimated $2K sold.
Smithfield Trust first reported a position in ARKG in Q4 2022 and held it in 7 quarters. The position peaked at $2K in Q2 2024. 238 funds tracked by Wall St. Rank hold ARKG as of Q3 2024.
- Smithfield Trust reported no remaining ARK Genomic Revolution ETF position as of Q3 2024 after selling out during the quarter.
- Smithfield Trust sold 71 ARK Genomic Revolution ETF shares in Q3 2024, an estimated $2K.
- Smithfield Trust first reported a position in ARK Genomic Revolution ETF in Q4 2022 and held it in 7 quarters.
- Smithfield Trust's ARK Genomic Revolution ETF position peaked at $2K in Q2 2024.
- 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2024.
Based on Smithfield Trust's 13F filing for Q3 2024, filed 12 Nov 2024.